Keywords: توسعه دارویی; Biopharmaceuticals; Drug development; Light stability assessment; Ligand binding; Magnetic circular dichroism; Circular dichroism;
مقالات ISI توسعه دارویی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: توسعه دارویی; Circadian rhythms; Logic of metabolism; Drug development; Evolution; Nanomaterials; Fuels
Keywords: توسعه دارویی; Bioactivation; Biotransformation; Cytochrome P450; Drug development; Drug discovery; Drug metabolism; Electrochemical generation; Electrochemistry; Metabolite synthesis; Reactive metabolite
Keywords: توسعه دارویی; Characterization; Drug development; Proliposome; Liposome; Manufacture;
Keywords: توسعه دارویی; forced conditions; ab initio calculations; chemical stability; oxidation; drug development; H2O2; mechanism; amine; acetonitrile; CO2;
Keywords: توسعه دارویی; Drug development; Animal models; Rodents; Nonhuman primates; Translational value; Recombinant proteins;
Keywords: توسعه دارویی; Amyotrophic lateral sclerosis; Clinical trialists; Drug development; Treatment;
Keywords: توسعه دارویی; Alzheimer's disease; Amyloid; Drug development; Innovation; Quantitative modeling;
Keywords: توسعه دارویی; Hepatocellular carcinoma; Systemic treatment; Drug development; Molecular targeted agents; Signalling pathway; Molecular biomarkers; Sorafenib;
Keywords: توسعه دارویی; Drug development; Preclinical drug screening; Focal epilepsy; Non-convulsive seizure; Pharmacoresistance; Statistical power analysis
Keywords: توسعه دارویی; Endocannabinoid; Fatty acid amide hydrolase; Monoacylglycerol lipase; Anxiety; Depression; Drug development
Keywords: توسعه دارویی; drug interactions; absorption; protein binding; regulatory science; drug development; drug transporters;
Keywords: توسعه دارویی; Aquaporin; Water; Glycerol; Volume regulation; Inhibition; Drug development; AQP; aquaporin; NMO; neuromyelitis optica;
Keywords: توسعه دارویی; AA; acrylic acid; Apo; apolipoprotein; BBB; blood-brain barrier; BCEC; brain capillary endothelial cells; BDNF; brain-derived neurotrophic factor; CNS; central nervous system; CNT; carbon nanotubes; FDA; U.S. Food and Drug Administration; GFAP; glial fibr
Keywords: توسعه دارویی; Breakthrough Therapy Designation; BTD; CDER; drug development; FDA; NME;
Keywords: توسعه دارویی; Aβ; amyloid beta; AD; Alzheimer's disease; ADDL; amyloid-β-derived diffusible ligand; ALS; amyotrophic lateral sclerosis; ApoE; apolipoprotein E; ART; antiretroviral therapy; BBB; blood-brain barrier; CNS; central nervous system; CSF; cerebral spina
Keywords: توسعه دارویی; Preformulation; Solid-state; Drug development; Formulation; Drug delivery; Process analytical technologies; Quality control; Dissolution testing;
Keywords: توسعه دارویی; ABL; Abelson; ALL; acute lymphocytic leukemia; AML; acute myeloid leukemia; APL; acute promyelocytic leukemia; BC; blast crisis; BCR; breakpoint cluster region; BMP; bone morphogenetic protein; CBP; CREB-binding protein; CDK; cyclin dependent kinase; CEBP
Keywords: توسعه دارویی; Schizophrenia; Bipolar disorder; Cognition; Cognitive impairment; Pharmacology; Drug development
Keywords: توسعه دارویی; Quinoline; Anticancer; Drug development;
Keywords: توسعه دارویی; Cancer heterogeneity; Tumor stroma; 3D; Spheroid; Drug development;
Keywords: توسعه دارویی; ADME; absorption, distribution, metabolism, excretion; BBB; blood-brain barrier; CEV; California encephalitis virus; CNS; central nervous system; CPE; cytopathic effect; ECMV; encephalomyocarditis virus; fLUC; firefly luciferase; FMV; Fort Morgan virus;
Keywords: توسعه دارویی; Fear extinction; Exposure therapy; Augmented relearning; Reconsolidation; Drug development; Cognitive enhancer; 5-HT; 5-hydroxytryptamine = serotonin; AC; adenylate cyclase; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; AMY; amygdala; BA;
Keywords: توسعه دارویی; Preclinical Alzheimer's disease; Prodromal Alzheimer's disease; Mild cognitive impairment; Diagnostic criteria; Food and Drug Administration; Regulatory guidance; Disease modification; Drug development; Clinical trials; Clinical outcomes; Composite scales
Keywords: توسعه دارویی; Paediatric medicines; Authorisation; European regulation; Drug development; Clinical trials;
Keywords: توسعه دارویی; Drug development; Systems biology; Open model
Keywords: توسعه دارویی; Antioxidant; Drug development; Oxidative damage; Pharmacology; Free radicals
Keywords: توسعه دارویی; POP, proof of principle; MED, minimally efficacious dose; ED50–100, doses at which 50–100% of patients had positive response; AED, anti-epileptic drugEpilepsy; Photosensitive; Proof of principle; Drug development
Keywords: توسعه دارویی; drug development; orphan drugs; rare disease; drug reimbursement;
Keywords: توسعه دارویی; Cost; Economics; Research and development; Influenza; Vaccine; Clinical trial; Risk; Biologic; Drug development;
Keywords: توسعه دارویی; Tuberculosis; Drug targets; Drug development; Target vulnerability; Whole-cell screens;
Keywords: توسعه دارویی; Animal model; Drug development; Translational value; Fit-for-purpose validation;
Keywords: توسعه دارویی; Cytotoxic cancer drugs; Antineoplastic drugs; Selective oncology drugs; Targeted therapeutics; Functional definition; Occupational health; Pharmaceutical manufacturing; Drug development;
Keywords: توسعه دارویی; Drug discovery; Drug development; Venoms to drugs; Snake venoms; Conus venoms; Phenotypic screening;
Keywords: توسعه دارویی; Bioeconomy; Biomedicine; Drug development; Innovation; Research and development; Strategy and models
Keywords: توسعه دارویی; Gastric cancer; Pathogenesis; Heterogeneity; Treatment; Drug development;
Keywords: توسعه دارویی; Medicinal plants; Principal component analysis; Randomization test; Ethnomedicine; Drug development;
Keywords: توسعه دارویی; Canada; Clinical trials; Drug development; Oncology; Experimental systems; Biomarkers;
Keywords: توسعه دارویی; Positron emission tomography; Dopamine re-uptake; DAT; Chronic treatment; Neurochemistry; Drug development
Keywords: توسعه دارویی; First in man pharmacokinetics; Oral drug absorption; Drug development;
Keywords: توسعه دارویی; Antiviral; Drug development; Herbal medicines; Natural products
Keywords: توسعه دارویی; Peptide drugs; Pharmaceutical industry; Drug discovery; Drug development
Keywords: توسعه دارویی; Proteasome; Natural product; High-throughput-screening; Methodology; Drug development;
Keywords: توسعه دارویی; Regulatory science; Drug development; Benefit-risk assessment; Market authorization; Post-marketing surveillance;
Keywords: توسعه دارویی; MS; mass spectrometry; UPLC; ultraperformance liquid chromatography; UPLC-ESI-QTOFMS; UPLC-electrospray ionization-quadrupole time-of-flight MS; LCMS; liquid chromatography-mass spectrometry; GCMS; gas chromatography-mass spectrometry; NMR; nuclea
Keywords: توسعه دارویی; Alzheimer's disease; Transgenic; Drug development; Review;
Keywords: توسعه دارویی; Drug development; Translational research; Inflammatory bowel disease; Colitis; Biomarkers; Endpoints; AA; alternative approaches; CD; Crohn's disease; 3Rs; Replacement, Reduction, Refinement; DHODH; dihydroorotate dehydrogenase; DNBS; dinitrobenzene sulph
Keywords: توسعه دارویی; DNMT1; Cancer; Non-nucleosides; Drug development
Keywords: توسعه دارویی; Seizures; Epilepsy; Drug development; Neuroprotection; Clinical trial; Antiepileptic
Keywords: توسعه دارویی; Purines; Transporter; Malaria; Drug development; Nucleoside/nucleobase transport; Parasite; Plasmodium vivax; Single-nucleotide polymorphism (SNP)ACT, Artemisinin-based Combination Therapies; CQ, chloroquine; EC50, concentration causing 50% of maximal eff